Mostrar el registro sencillo del ítem
Conotoxins as tools to understand the physiological function of voltage-gated calcium (CaV) channels
dc.contributor.author | Ramírez D. | |
dc.contributor.author | Gonzalez W. | |
dc.contributor.author | Fissore R.A. | |
dc.contributor.author | Carvacho I. | |
dc.date.accessioned | 2020-09-02T22:26:32Z | |
dc.date.available | 2020-09-02T22:26:32Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.3390/md15100313 | |
dc.identifier.citation | 15, 10, - | |
dc.identifier.issn | 16603397 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5951 | |
dc.description | Voltage-gated calcium (CaV) channels are widely expressed and are essential for the completion of multiple physiological processes. Close regulation of their activity by specific inhibitors and agonists become fundamental to understand their role in cellular homeostasis as well as in human tissues and organs. CaV channels are divided into two groups depending on the membrane potential required to activate them: High-voltage activated (HVA, CaV1.1–1.4; CaV2.1–2.3) and Low-voltage activated (LVA, CaV3.1–3.3). HVA channels are highly expressed in brain (neurons), heart, and adrenal medulla (chromaffin cells), among others, and are also classified into subtypes which can be distinguished using pharmacological approaches. Cone snails are marine gastropods that capture their prey by injecting venom, “conopeptides”, which cause paralysis in a few seconds. A subset of conopeptides called conotoxins are relatively small polypeptides, rich in disulfide bonds, that target ion channels, transporters and receptors localized at the neuromuscular system of the animal target. In this review, we describe the structure and properties of conotoxins that selectively block HVA calcium channels. We compare their potency on several HVA channel subtypes, emphasizing neuronal calcium channels. Lastly, we analyze recent advances in the therapeutic use of conotoxins for medical treatments. © 2017 by the authors. | |
dc.language.iso | en | |
dc.publisher | MDPI AG | |
dc.subject | Conotoxins | |
dc.subject | Therapeutic potential | |
dc.subject | Voltage-gated calcium (CaV) channels | |
dc.subject | ω-conotoxin structure | |
dc.subject | alpha conotoxin | |
dc.subject | chi conotoxin | |
dc.subject | conotoxin | |
dc.subject | delta conotoxin | |
dc.subject | epsilon conotoxin | |
dc.subject | gamma conotoxin | |
dc.subject | iota conotoxin | |
dc.subject | kappa conotoxin | |
dc.subject | mu conotoxin | |
dc.subject | omega conotoxin | |
dc.subject | omega conotoxin CVID | |
dc.subject | omega conotoxin MVIIA | |
dc.subject | rho conotoxin | |
dc.subject | sigma conotoxin | |
dc.subject | tau conotoxin | |
dc.subject | unclassified drug | |
dc.subject | voltage gated calcium channel | |
dc.subject | calcium channel | |
dc.subject | calcium channel blocking agent | |
dc.subject | conotoxin | |
dc.subject | adrenal medulla | |
dc.subject | brain nerve cell | |
dc.subject | chromaffin cell | |
dc.subject | chronic pain | |
dc.subject | disulfide bond | |
dc.subject | drug activity | |
dc.subject | drug potency | |
dc.subject | drug structure | |
dc.subject | heart | |
dc.subject | homeostasis | |
dc.subject | human | |
dc.subject | membrane potential | |
dc.subject | nonhuman | |
dc.subject | pharmacological blocking | |
dc.subject | protein expression | |
dc.subject | protein function | |
dc.subject | Review | |
dc.subject | snail | |
dc.subject | animal | |
dc.subject | chemistry | |
dc.subject | drug effect | |
dc.subject | metabolism | |
dc.subject | Animals | |
dc.subject | Calcium Channel Blockers | |
dc.subject | Calcium Channels | |
dc.subject | Conotoxins | |
dc.subject | Humans | |
dc.subject | Membrane Potentials | |
dc.subject | Snails | |
dc.title | Conotoxins as tools to understand the physiological function of voltage-gated calcium (CaV) channels | |
dc.type | Review |